|Articles|January 18, 2021
Application Note: Seamless Method Transfer to the Agilent 1290 Infinity II Bio LC System Peptide-mapping analysis shows excellent performance and high method compatibility compared to the Agilent 1290 Infinity II LC System
Author(s)Agilent
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
CDC Revises Childhood Immunization Schedule, Shifting Demand Dynamics
2
Industry Outlook 2026: Biopharma Braces for Economic Upheaval While Eyeing AI-Driven Transformation (Part 1)
3
New AI Oncology Alliance Highlights Industry Push for Scalable Genomics
4
GSK Advances Vaccine Delivery and Hepatitis B Treatment
5